Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol vs Hydralazine for Severe Hypertension in Pregnancy
NCT02050529Phase 2Completed
- Sponsor
- Dow University of Health Sciences
- Start
- Oct 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of labetalol in hypertension (HTN), preeclampsia, eclampsia, sponsored by Dow University of Health Sciences. Started Oct 2012; status: completed.
02
Drugs
labetalol
03
Conditions
hypertension (HTN)preeclampsiaeclampsia
Beyond the preview
Go deeper on NCT02050529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02050529.